Watson, send me an e-mail at email@example.com and let me know your interest in the private nerve conduction company that had a recent published study showing soft tissue injuries were closed 6.5 times faster with our use.
The biggest market we have is workers' comp since we prove "when" the injury occurred thru blood flow patterns, acute or chronic, and exactly where the nerve problem is, if there is one at all. Most carpal tunnell claims are bogus, yet can't be proven to not be true or caused by occupational employment. We can .
Look again. The reference to the write off of $1.7 and $.7 million was in the 2nd quarter of LAST year, not this year.
So, they still lost $2.1 THIS quarter on lower revenue. They have a long way to go if ADVANCE is only 16% of revenue to make up for the declining Stat revenue which is never going to recover with low reimbursement codes as are proposed.
NURO is at least a year from recovering, but maybe this is the bottoming out.